Serelli-Lee, V.; Ito, K.; Koibuchi, A.; Tanigawa, T.; Ueno, T.; Matsushima, N.; Imai, Y.
A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies. J. Pers. Med. 2022, 12, 669.
https://doi.org/10.3390/jpm12050669
AMA Style
Serelli-Lee V, Ito K, Koibuchi A, Tanigawa T, Ueno T, Matsushima N, Imai Y.
A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies. Journal of Personalized Medicine. 2022; 12(5):669.
https://doi.org/10.3390/jpm12050669
Chicago/Turabian Style
Serelli-Lee, Victoria, Kazumi Ito, Akira Koibuchi, Takahiko Tanigawa, Takayo Ueno, Nobuko Matsushima, and Yasuhiko Imai.
2022. "A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies" Journal of Personalized Medicine 12, no. 5: 669.
https://doi.org/10.3390/jpm12050669
APA Style
Serelli-Lee, V., Ito, K., Koibuchi, A., Tanigawa, T., Ueno, T., Matsushima, N., & Imai, Y.
(2022). A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies. Journal of Personalized Medicine, 12(5), 669.
https://doi.org/10.3390/jpm12050669